skip to primary navigationskip to content

Cambridge Infectious Diseases

An Interdisciplinary Research Centre at The University of Cambridge

Studying at Cambridge

 

Drugs and Vaccines

Pills photo 590 x 288Work in this area is undertaken in numerous research groups and collaborations across Cambridge, particularly in the Departments of Pharmacology, Pathology, Biochemistry, Veterinary Medicine.

The Cambridge Molecular Therapeutics Programme, based in the Hutchison-MRC Research Centre is an interdisciplinary initiative that aims to explore new scientific paradigms for the discovery and development of small molecule therapeutics

Recent highlights include

People specializing in this area

Research paves way for the development of a vaccine for the contagious cancer which is driving Tasmanian devils to the brink of extinction.

Read more

Targeting the ‘conversations’ that bacteria have with one another could herald a new generation of therapeutics that curb the virulence of infectious microbes.

Read more

Screening method created to expedite the development of new drugs in the fight against tropical diseases such as malaria and African sleeping sickness.

Read more
130225 hivcredit cynthia goldsmith centers for disease control and prevention 2885 x432

Although anti-HIV drugs can significantly prolong life, patients must take the drugs for the rest of their lives. New approaches to therapeutics may hold the answer to finding a cure for HIV.

Cambridge scientists, and their map-making skills, are contributing to an annual worldwide public health endeavour – the race to select a vaccine against seasonal flu.

Read more

Breakthrough could prevent future bird flu epidemics.

Read more

A ‘dipstick’ test that detects Hepatitis B within 30 minutes – and could be used in some of the world’s poorest countries – has been given the green light for use in the European Union.

Read more

A new multidisciplinary research programme aims to develop a single vaccine that will combat four major respiratory pathogens of pigs.

Read more